|
|
|
Endocrine Management of Breast Cancer
This text reviews the latest ideas in tumour biology, explains the pharmacologic basis of the agents used, and discusses how they are applied in clinical practice Part One presents an overview of the clinical importance of endocrine therapy, and describes the applications of the principal classes of drug, including anti-oestrogens, aromatase inhibitors, progestins, and progesterone receptor antagonists This section also includes discussion of ovarian ablation Part Two deals with the biological aspects of endocrine therapies, and relates current understanding of tumour biology and the pharmacologic basis of hormonal agents to their clinical applications Among the topics covered are resistance and sensitivity to therapy Part Three outlines future strategies, in particular the use of combination endocrine therapy, adjuvant growth factor therapy and the use of anti-invasive agents
| Author: |
John F R Robertson, Robert I Nicholson, Daniel F Hayes |
| ISBN: |
190186572X |
| Publisher: |
Martin Dunitz Publishing |
| Binding: |
Hardcover |
| Year Published: |
May 2002 |
| No. of Pages: |
250 |
| Contents: |
PART 1: THE USE OF ENDOCRINE THERAPIES IN CLINICAL PRACTICE * Overview/Concepts *Ovarian Ablation * Anti-Oestrogens (Partial Agonist) * Anti-Oestrogens (Specific) * Aromatase Inhibitors * Progestins * Progesterone receptor Antagonists * Therapies for ER(-) disease
PART 2: BIOLOGICAL ASPECTS OF ENDOCRINE THERAPIES * Introduction * Factors Predicting Sensitivity to Tamoxifen * Acquired Anti-Oestrogen Resistance * Acquired Endocrine Insensitivity * Effects of Aromatase Inhibitors on Breast Cancer * Effects of Progesterone Receptor Antagonists on Breast Cancer * Explaining De Novo Resistance * Endo (Tam) + GLA
PART 3: FUTURE STRATEGIES * Clinical * Biological |
|
| About The Author: |
John F R Robertson : Department of Surgery, City Hospital, Nottingham, UK Robert I Nicholson : The Tenovus Cancer Research Centre, The Welsh School of Pharmacy, Cardiff University, UK Daniel F Hayes MD: Clinical Director, Breast Cancer Program, Lombardi Cancer Center, Georgetown University Medical Center, Washington DC, USA |
|
|
|
Please note
Publishers prices can change unexpectedly. If the price of your book has changed we will contact you.
|
|
|
|
|
|
Privacy Policy © 2009 Mi-tec Media Pty. Ltd.
|